Systematic Characterization of Epidemiology, Antifungal Susceptibility, Risk Factors and Outcomes of Candidaemia: A Six-Year Chinese Study

References

• Barac A, Cevik M, Colovic N, et al. Investigation of a healthcare-associated Candida tropicalis candidiasis cluster in a haematology unit and a systematic review of nosocomial outbreaks. Mycoses. 2020;63:326–333. doi:10.1111/myc.13048
   PubMed Web of Science ®Google Scholar
• Li Y, Du M, Chen LA, et al. Nosocomial bloodstream infection due to Candida spp. in China: species distribution, clinical features, and outcomes. Mycopathologia. 2016;181:485–495. doi:10.1007/s11046-016-9997-3
   PubMed Web of Science ®Google Scholar
• Posteraro B, De Carolis E, Criscuolo M, et al. Candidaemia in haematological malignancy patients from a SEIFEM study: epidemiological patterns according to antifungal prophylaxis. Mycoses. 2020;63:900–910. doi:10.1111/myc.13130
   PubMed Web of Science ®Google Scholar
• Samonis G, Kofteridis DP, Saloustros E, et al. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data. Scand J Infect Dis. 2008;40:414–419. doi:10.1080/00365540701765657
   PubMed Web of Science ®Google Scholar
• Toda M, Williams SR, Berkow EL, et al. Population-based active surveillance for culture-confirmed Candidemia - four sites, United States, 2012–2016. MMWR Surveill Summ. 2019;68:1–15. doi:10.15585/mmwr.ss6808a1
   PubMed Web of Science ®Google Scholar
• Schroeder M, Weber T, Denker T, et al. Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany: a single-center retrospective 10-year analysis. Ann Intensive Care. 2020;10:142. doi:10.1186/s13613-020-00755-8
   PubMed Web of Science ®Google Scholar
• Fortún J, Gioia F. Invasive candidiasis in the neutropenic patient. Rev Esp Quimioter. 2017;30(Suppl 1):22–25.
   Google Scholar
• Wu PF, Liu WL, Hsieh MH, et al. Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients. Emerg Microbes Infect. 2017;6:e87. doi:10.1038/emi.2017.74
   PubMed Web of Science ®Google Scholar
• Alkharashi N, Aljohani S, Layqah L, et al. Candida bloodstream infection: changing pattern of occurrence and antifungal susceptibility over 10 years in a tertiary care Saudi hospital. Can J Infect Dis Med Microbiol. 2019;2019:2015692. doi:10.1155/2019/2015692
   PubMed Web of Science ®Google Scholar
• Zheng YJ, Xie T, Wu L, et al. Epidemiology, species distribution, and outcome of nosocomial Candida spp. bloodstream infection in Shanghai: an 11-year retrospective analysis in a tertiary care hospital. Ann Clin Microbiol Antimicrob. 2021;20:34. doi:10.1186/s12941-021-00441-y
   PubMed Web of Science ®Google Scholar
• Zhang W, Song X, Wu H, et al. Epidemiology, risk factors and outcomes of Candida albicans vs. non- albicans candidaemia in adult patients in Northeast China. Epidemiol Infect. 2019;147:e277. doi:10.1017/S0950268819001638
   PubMed Web of Science ®Google Scholar
• Xiao M, Chen SC, Kong F, et al. Distribution and antifungal susceptibility of Candida species causing candidemia in China: an Update from the CHIF-NET study. J Infect Dis. 2020;221:S139–S147. doi:10.1093/infdis/jiz573
   PubMed Web of Science ®Google Scholar
• Matos T, Lejko Zupanc T, Skofljanec A, et al. Candidaemia in Central Slovenia: a 12-year retrospective survey. Mycoses. 2021;64:753–762. doi:10.1111/myc.13278
   Web of Science ®Google Scholar
• Siopi M, Tarpatzi A, Kalogeropoulou E, et al. Epidemiological trends of fungemia in Greece with a focus on candidemia during the recent financial crisis: a 10-year survey in a tertiary care academic hospital and review of literature. Antimicrob Agents Chemother. 2020;64:01516–01519. doi:10.1128/AAC.01516-19
   Web of Science ®Google Scholar
• Liu WL, Huang YT, Hsieh MH, et al. Clinical characteristics of Candida tropicalis fungaemia with reduced triazole susceptibility in Taiwan: a multicentre study. Int J Antimicrob Agents. 2019;53:185–189. doi:10.1016/j.ijantimicag.2018.10.015
   Web of Science ®Google Scholar
• Ko JH, Jung DS, Lee JY, et al. Poor prognosis of Candida tropicalis among non-albicans candidemia: a retrospective multicenter cohort study, Korea. Diagn Microbiol Infect Dis. 2019;95:195–200. doi:10.1016/j.diagmicrobio.2019.05.017
   Web of Science ®Google Scholar
• Doğan Ö, Yeşilkaya A, Menekşe Ş, et al. Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: a multicentre observational study by the Turkish Fungal Infections Study Group. Int J Antimicrob Agents. 2020;56:105992. doi:10.1016/j.ijantimicag.2020.105992
   Web of Science ®Google Scholar
• Al-Musawi TS, Alkhalifa WA, Alasaker NA, et al. A seven-year surveillance of Candida bloodstream infection at a university hospital in KSA. J Taibah Univ Med Sci. 2021;16:184–190. doi:10.1016/j.jtumed.2020.12.002
   Web of Science ®Google Scholar
• Yang CC, Fong Y, Lin LC, et al. The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices. Eur J Cardiothorac Surg. 2018;53:235–240. doi:10.1093/ejcts/ezx215
   Web of Science ®Google Scholar
• Oviaño M, Rodríguez-Sánchez B. MALDI-TOF mass spectrometry in the 21st century clinical microbiology laboratory. Enferm Infecc Microbiol Clin. 2021;39:192–200. doi:10.1016/j.eimc.2020.02.027
   Web of Science ®Google Scholar
• Lei J, Xu J, Wang T. In vitro susceptibility of Candida spp. to fluconazole, itraconazole and voriconazole and the correlation between triazoles susceptibility: results from a five-year study. J Mycol Med. 2018;28:310–313. doi:10.1016/j.mycmed.2018.03.005
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antifungal Susceptibility Testing of Yeasts, M60. 2nd ed. Clinical and Laboratory Standards Institute; 2020.
   Google Scholar
• Arendrup MC, Friberg N, Mares M, et al. How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST). Clin Microbiol Infect. 2020;26:1464–1472. doi:10.1016/j.cmi.2020.06.007
   PubMed Web of Science ®Google Scholar
• Prigitano A, Cavanna C, Passera M, et al. Evolution of fungemia in an Italian region. J Mycol Med. 2020;30:100906. doi:10.1016/j.mycmed.2019.100906
   PubMed Web of Science ®Google Scholar
• Israel S, Amit S, Israel A, et al. The epidemiology and susceptibility of candidemia in Jerusalem, Israel. Front Cell Infect Microbiol. 2019;9:352. doi:10.3389/fcimb.2019.00352
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Turnidge JD, et al. Twenty years of the SENTRY antifungal surveillance program: results for candida species from 1997–2016. Open Forum Infect Dis. 2019;6:S79–S94. doi:10.1093/ofid/ofy358
   PubMed Web of Science ®Google Scholar
• Treviño-Rangel RJ, Peña-López CD, Hernández-Rodríguez PA, et al. Association between Candida biofilm-forming bloodstream isolates and the clinical evolution in patients with candidemia: an observational nine-year single center study in Mexico. Rev Iberoam Micol. 2018;35:11–16. doi:10.1016/j.riam.2017.01.005
   Web of Science ®Google Scholar
• Yamin D, Husin A, Harun A. Distribution of candidemia in Malaysian tertiary care hospital revealed predominance of Candida parapsilosis. Trop Biomed. 2020;37:903–910.
   Web of Science ®Google Scholar
• Seneviratne CJ, Rajan S, Wong SS, et al. Antifungal susceptibility in serum and virulence determinants of Candida bloodstream isolates from Hong Kong. Front Microbiol. 2016;7:216. doi:10.3389/fmicb.2016.00216
   PubMed Web of Science ®Google Scholar
• Chen CY, Tien FM, Sheng WH, et al. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008–2013. Int J Antimicrob Agents. 2017;49:272–281. doi:10.1016/j.ijantimicag.2016.11.009
   PubMed Web of Science ®Google Scholar
• You L, Yao C, Yang F, et al. Echinocandins versus amphotericin B against Candida tropicalis fungemia in adult hematological patients with neutropenia: a multicenter retrospective cohort study. Infect Drug Resist. 2020;13:2229–2235. doi:10.2147/IDR.S258744
   Web of Science ®Google Scholar
• Kim SH, Choi JK, Cho SY, et al. Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents. Med Mycol. 2018;56:197–206. doi:10.1093/mmy/myx038
   Web of Science ®Google Scholar
• Megri Y, Arastehfar A, Boekhout T, et al. Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures. Antimicrob Resist Infect Control. 2020;9:50. doi:10.1186/s13756-020-00710-z
   Web of Science ®Google Scholar
• Puig-Asensio M, Ruiz-Camps I, Fernández-Ruiz M, et al. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain. Clin Microbiol Infect. 2015;21:491 e491–410. doi:10.1016/j.cmi.2014.12.027
   Web of Science ®Google Scholar
• Wallis LS, Stull CM, Rakita U, et al. Postoperative Candida infection following complex periocular reconstruction. Plast Reconstr Surg Glob Open. 2021;9:e3891. doi:10.1097/GOX.0000000000003891
   Google Scholar
• Adámková V, Vaňková A, Ulrych J, et al. Analýza záchytu kvasinek u pacientů po břišním chirurgickém výkonu. Rozhl Chir. 2017;96:426–431. Czech.
   Google Scholar
• Xia R, Wang D. Risk factors of invasive candidiasis in critical cancer patients after various gastrointestinal surgeries: a 4-year retrospective study. Medicine. 2019;98:e17704. doi:10.1097/MD.0000000000017704
   Web of Science ®Google Scholar
• Altintop YA, Ergul AB, Koc AN, et al. Evaluation of Candida colonization and use of the Candida colonization index in a paediatric intensive care unit: a prospective observational study. Infez Med. 2019;27:159–167.
   Google Scholar
• Yamin DH, Husin A, Harun A. Risk factors of Candida parapsilosis catheter-related bloodstream infection. Front Public Health. 2021;9:631865. doi:10.3389/fpubh.2021.631865
   Web of Science ®Google Scholar
• Boyce JM, Dumigan DG, Havill NL, et al. A multi-center outbreak of Candida tropicalis bloodstream infections associated with contaminated hemodialysis machine prime buckets. Am J Infect Control. 2021;49:1008–1013. doi:10.1016/j.ajic.2021.02.014
   Web of Science ®Google Scholar
• Herek TC, Menegazzo VR, Ogaki MB, et al. Biofilm formation by blood isolates of Candida parapsilosis sensu stricto in the presence of a hyperglycidic solution at comparable concentrations of total parenteral nutrition. Rev Soc Bras Med Trop. 2019;52:e20180182. doi:10.1590/0037-8682-0182-2018
   Web of Science ®Google Scholar
• Phua AI, Hon KY, Holt A, et al. Candida catheter-related bloodstream infection in patients on home parenteral nutrition - Rates, risk factors, outcomes, and management. Clin Nutr ESPEN. 2019;31:1–9. doi:10.1016/j.clnesp.2019.03.007
   Web of Science ®Google Scholar
• Santolaya ME, Thompson L, Benadof D, et al. A prospective, multi-center study of Candida bloodstream infections in Chile. PLoS One. 2019;14:e0212924. doi:10.1371/journal.pone.0212924
   Web of Science ®Google Scholar
• Tiraboschi IN, Pozzi NC, Farías L, et al. Epidemiología, especies, resistencia antifúngicay evolución de las candidemias en un hospital universitario de Buenos Aires, Argentina, durante 16 años. Rev Chilena Infectol. 2017;34:431–440. Spanish. doi:10.4067/S0716-10182017000500431
   Web of Science ®Google Scholar
• Fernández-Ruiz M, Puig-Asensio M, Guinea J, et al. Candida tropicalis bloodstream infection: incidence, risk factors and outcome in a population-based surveillance. J Infect. 2015;71:385–394. doi:10.1016/j.jinf.2015.05.009
   Web of Science ®Google Scholar